EcoDrugPlus

Hck Proto-Oncogene, Src Family Tyrosine Kinase

Ensembl ID : ENSNBRG00000020008
Gene Symbol: HCK
3 Cross references
202 Possible Orthologues:

Map Kinase-Activated Protein Kinase 5-Like

Ensembl ID : ENSNBRG00000015746
Gene Symbol: LOC102786456
3 Cross references
179 Possible Orthologues:

Map Kinase-Interacting Serine/threonine-Protein Kinase 2-Like

Ensembl ID : ENSNBRG00000021349
Gene Symbol: LOC102783428
3 Cross references
208 Possible Orthologues:

Mapk Activated Protein Kinase 2

Ensembl ID : ENSNBRG00000012311
Gene Symbol: MAPKAPK2
3 Cross references
187 Possible Orthologues:

Nad(P)h Dehydrogenase [Quinone] 1-Like

Ensembl ID : ENSNBRG00000010883
Gene Symbol: LOC102788053
3 Cross references
186 Possible Orthologues:

Nadph Oxidase 4

Ensembl ID : ENSNBRG00000015397
Gene Symbol: NOX4
4 Cross references
151 Possible Orthologues:

Npc1 Like Intracellular Cholesterol Transporter 1

Ensembl ID : ENSNBRG00000017055
Gene Symbol: NPC1L1
4 Cross references
189 Possible Orthologues:

P-Selectin-Like

Ensembl ID : ENSNBRG00000002070
Gene Symbol: LOC102782066
3 Cross references
48 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSNBRG00000004118
Gene Symbol: LOC102792555
3 Cross references
195 Possible Orthologues:

P2x Purinoceptor 3-Like

Ensembl ID : ENSNBRG00000004881
Gene Symbol: LOC102793598
3 Cross references
192 Possible Orthologues:

P2x Purinoceptor 7-Like

Ensembl ID : ENSNBRG00000015740
Gene Symbol: LOC102792003
3 Cross references
191 Possible Orthologues:

P2y Purinoceptor 12-Like

Ensembl ID : ENSNBRG00000002669
Gene Symbol: LOC102777277
3 Cross references
180 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).